Dr Michael Dennis



  • Fee assured

Specialises in

  • Haemato-oncology

About me

Mike Dennis is an established national expert in myeloid disease, a committee member of the NCRN working groups for AML and myelodysplasia, where his roles include Chief investigator (Li1) and Co-chief investigator (AML 19).

His research focus is around clinical trial development for optimal therapy in AML of traditional and emerging agents, from site development and delivery of phase 1 studies to international trial governance and oversight.

He was appointed as a Consultant Haematologist at The Christie, Manchester in 2004. He qualified in Medicine from the University of Dundee, completed his physician’s training in Liverpool before undertaking his first Haematology post in Australia. He then completed his Haematology training, including a MD, from the University of Liverpool.

Areas of interest

• Leukaemias (AML and CML)
• Myelodysplastic syndrome (MDS)
• Myeloproliferative disorders (Myelofibrosis, ET...)
• Aplastic aneamia
• Bone marrow transplantation

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0004

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 28 days - (5-50)

    The Christie Clinic (5-50)

Edit details Print page

The information contained on Finder is submitted by consultants, therapists and facilities, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the data and information on Finder and our website terms of use here.